30 Day Trial

Maxx Orthopedics Gains FDA Clearance for the Freedom Knee Ultra-Congruent Liner

Share:

Maxx Orthopedics was granted FDA 510(k) clearance to market the Freedom® Ultra-Congruent liner, part of the Freedom Knee® system.

The component is designed to achieve a higher level of constraint than is typically achieved with traditional cruciate-retaining knees. It features a deep anterior patellar cut-out to allow for tendon clearance, a prominent anterior lip to prevent anterior subluxation of the femur and a prominent posterior lip that resists posterior translation of the femur. Thicknesses vary in 1mm increments throughout the size range.

Source: Maxx Medical